ID
24992
Beschrijving
A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00466440
Link
https://clinicaltrials.gov/show/NCT00466440
Trefwoorden
Versies (1)
- 23-08-17 23-08-17 -
Geüploaded op
23 augustus 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Prostate Cancer NCT00466440
Eligibility Prostate Cancer NCT00466440
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Able to swallow Pills Lacking
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C2712086
- UMLS CUI [1,2]
- C0994475
- UMLS CUI [1,3]
- C0332268
Beschrijving
Illness Serious | Exception Prostate carcinoma
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0221423
- UMLS CUI [1,2]
- C0205404
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0600139
Beschrijving
Investigational New Drugs
Datatype
boolean
Alias
- UMLS CUI [1]
- C0013230
Beschrijving
Heart condition Serious
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3842523
- UMLS CUI [1,2]
- C0205404
Beschrijving
cancer treatment
Datatype
boolean
Alias
- UMLS CUI [1]
- C0920425
Similar models
Eligibility Prostate Cancer NCT00466440
- StudyEvent: Eligibility
C1706276 (UMLS CUI [1,2])
C0031834 (UMLS CUI [1,3])
C0028900 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C1999232 (UMLS CUI [2,3])
C0332197 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C0994475 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
C0205404 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])